Peptomyc Announces Leadership Transition to Support Next Phase of Growth

Barcelona, [July 2nd, 2025] — The Board of Directors of Peptomyc S.L., a pioneering biotech company developing innovative cancer therapies targeting the MYC oncoprotein, is pleased to announce a strategic leadership transition aimed at accelerating the company’s business development and clinical expansion efforts. Effective July 2nd, 2025, Jesus Martin Garcia will assume the role of Chief Executive Officer (CEO). […]